Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis-Reference-Cited by-同舟云学术

Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis

Published:2023-04 Issue:4 Volume:130 Page:500-507.e3
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Leung Donald Y.M.^ORCID,Paller Amy S.,Zaenglein Andrea L.,Tom Wynnis L.,Ong Peck Y.,Venturanza May E.,Kuligowski Michael E.,Li Qian,Gong Xiaohua,Lee Mark S.

Funder

Incyte

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference29 articles.

1. Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study;Silverberg;Ann Allergy Asthma Immunol,2021

2. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three;Odhiambo;J Allergy Clin Immunol,2009

3. Public health burden and epidemiology of atopic dermatitis;Silverberg;Dermatol Clin,2017

4. The prevalence of childhood atopic eczema in a general population;Kay;J Am Acad Dermatol,1994

5. Pathophysiology and management of mild to moderate pediatric atopic dermatitis;Sayaseng;J Pediatr Health Care,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus;The Journal of Pediatrics: Clinical Practice;2024-12

2. Topical Therapy for Atopic Dermatitis;Dermatologic Clinics;2024-10

3. Biological Therapies for Pediatric Atopic Dermatitis - A Review;Current Pediatric Reviews;2024-08

4. Case series of topical 1.5% ruxolitinib cream for pediatric vitiligo;JAAD Case Reports;2024-04

5. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations;Annals of Allergy, Asthma & Immunology;2023-12